Effect of a functional single nucleotide polymorphism in the 2',3'-cyclic nucleotide 3'-phosphodiesterase gene on the expression of oligodendrocyte-related genes in schizophrenia

Psychiatry Clin Neurosci. 2008 Feb;62(1):103-8. doi: 10.1111/j.1440-1819.2007.01786.x.

Abstract

Aims: Although the expression of oligodendrocyte-related genes in post-mortem brains of patients with schizophrenia is consistently reported to be downregulated, the cause of the change remains unclear. The A-allele of rs2070106 within the 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP), an oligodendrocyte-related gene, was reported to show reduced expression compared with the G-allele, and proposed to be associated with schizophrenia.

Methods: The effect of the rs2070106 genotype on the expression of CNP and other oligodendrocyte-related genes was examined using data previously obtained from DNA microarray studies of post-mortem brains.

Results: It was found that the effect of rs2070106 genotype on the CNP expression was transcript specific, and that the genotype was not associated with the expression of other oligodendrocyte-related genes.

Conclusions: The rs207016 genotype is not likely to contribute to the reported coordinated down-regulation of oligodendrococyte-related genes in schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2',3'-Cyclic-Nucleotide Phosphodiesterases / genetics*
  • Bipolar Disorder / diagnosis
  • Bipolar Disorder / genetics
  • Bipolar Disorder / pathology
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / genetics
  • Depressive Disorder, Major / pathology
  • Down-Regulation / genetics
  • Gene Expression / genetics*
  • Gene Expression Profiling
  • Genotype
  • Humans
  • Myelin Proteins / genetics
  • Oligodendroglia / metabolism*
  • Oligodendroglia / pathology
  • Oligonucleotide Array Sequence Analysis
  • Polymorphism, Single Nucleotide / genetics*
  • Prefrontal Cortex / pathology
  • Schizophrenia / diagnosis
  • Schizophrenia / genetics*
  • Schizophrenia / pathology

Substances

  • Myelin Proteins
  • 2',3'-Cyclic-Nucleotide Phosphodiesterases